Efficacy and safety of tolvaptan in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of tolvaptan in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials

Published:2023-10-03 Issue:10 Volume:17 Page:1041-1051
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Chai Lu¹²,Li Zhe¹²,Wang Ting¹²,Wang Ran¹,Pinyopornpanish Kanokwan³,Cheng Gang²,Qi Xingshun¹²^ORCID

Affiliation:

1. Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China

2. NMPA Key Laboratory for Research and Evaluation of Drug Regulatory Technology, Shenyang Pharmaceutical University, Shenyang, China

3. Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2023.2267421

Reference61 articles.

1. Liver cirrhosis

2. Treatment of Patients with Cirrhosis

3. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017;GBD 2017 Causes of Death Collaborators;Lancet,2017

4. Compensated cirrhosis: Natural history and prognostic factors

5. Chinese guidelines on the management of ascites and its related complications in cirrhosis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ascites in cirrhotic patients: a comprehensive review;Exploration of Digestive Diseases;2024-08-26